ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 78 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $769,920 | -41.2% | 160,400 | -8.0% | 0.00% | – |
| Q2 2023 | $1,309,992 | +548013.8% | 174,433 | +229.7% | 0.00% | – |
| Q1 2023 | $239 | -75.8% | 52,906 | -39.5% | 0.00% | -100.0% |
| Q4 2022 | $986 | -100.0% | 87,446 | -62.3% | 0.00% | 0.0% |
| Q3 2022 | $2,222,000 | -36.0% | 232,162 | -45.9% | 0.00% | -50.0% |
| Q2 2022 | $3,473,000 | +504.0% | 429,280 | +1161.4% | 0.00% | – |
| Q1 2022 | $575,000 | -81.1% | 34,032 | -76.0% | 0.00% | -100.0% |
| Q4 2021 | $3,046,000 | +355.3% | 141,718 | +1058.8% | 0.00% | – |
| Q2 2021 | $669,000 | +0.8% | 12,230 | +35.9% | 0.00% | – |
| Q1 2021 | $664,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
| Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
| Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
| Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
| Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
| BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
| Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
| Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
| Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |